$210,000 of CENOVUS US CORPORATION (FKA CENOVUS ENERGY) lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Renewable Fuel Standard (RFS) issues relating to the Small Refinery Exemption program, RIN obligations, and Reid Vapor Pressure requirements Issues relating to EPA Refinery Risk Management Plan Issues related to H.R. 1435 / S. 2090 (Preserving Choice in Vehicle Purchases Act) and potential restrictions on consumer purchases of internal combustion engine vehicles Potential impacts of tariffs on energy imports"
You can find more data on corporate lobbying on Quiver Quantitative.
CVE Hedge Fund Activity
We have seen 158 institutional investors add shares of CVE stock to their portfolio, and 222 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS added 26,127,617 shares (+15.8%) to their portfolio in Q4 2024, for an estimated $395,833,397
- CAPITAL RESEARCH GLOBAL INVESTORS removed 20,029,013 shares (-45.0%) from their portfolio in Q4 2024, for an estimated $303,439,546
- MILLENNIUM MANAGEMENT LLC added 13,499,788 shares (+84.3%) to their portfolio in Q4 2024, for an estimated $204,521,788
- D. E. SHAW & CO., INC. added 10,616,194 shares (+304.5%) to their portfolio in Q4 2024, for an estimated $160,835,339
- FMR LLC removed 9,334,470 shares (-16.9%) from their portfolio in Q4 2024, for an estimated $141,417,220
- 1832 ASSET MANAGEMENT L.P. removed 7,873,005 shares (-97.7%) from their portfolio in Q4 2024, for an estimated $119,276,025
- BANK OF AMERICA CORP /DE/ removed 6,723,011 shares (-49.8%) from their portfolio in Q4 2024, for an estimated $101,853,616
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CVE Analyst Ratings
Wall Street analysts have issued reports on $CVE in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 04/15/2025
- Raymond James issued a "Outperform" rating on 12/13/2024
To track analyst ratings and price targets for CVE, check out Quiver Quantitative's $CVE forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
